📊 Score Breakdown
Offering Ability
60
Cash Runway
0
Float Risk
2
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
37%
📉 Score Deterioration
40%
• Score rose 17 points recently (worsening)
💰 Capital Raise
38%
• Active shelf registration ($150M, 31% of market cap)
• Active ATM program with $19M remaining capacity
🔄 Reverse Split
30%
• 50-day avg $1.07 approaching $1 threshold
💹 Market Data
Market Cap$489.50M
Shares Outstanding422.82M
Float377.58M
Cash$269.29M
Debt$184.94M
Short InterestN/A
🏛 Institutional Holdings
7.7% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
📉 Short Interest
Short Interest23.02M
Days to Cover3.7
% of Float6.1%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Mar 31, 2025
xbrl
XBRL CONVERTIBLE
Jun 30, 2022
4
INSIDER TRANSACTION
Apr 02, 2026
4
INSIDER TRANSACTION
Apr 02, 2026
4
INSIDER TRANSACTION
Apr 02, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for CGC
📊 CGC FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 CGC Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.